Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (5) , 600-603
- https://doi.org/10.1016/0277-5379(90)90087-a
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Inhibition of Aromatase With CGS 16949A in Postmenopausal Women*Journal of Clinical Endocrinology & Metabolism, 1989
- In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949ASteroids, 1987
- Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitorsCritical Reviews in Oncology/Hematology, 1986
- Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630British Journal of Cancer, 1986
- Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinomaBreast Cancer Research and Treatment, 1986
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- Source of Estrogen Production in Postmenopausal Women1Journal of Clinical Endocrinology & Metabolism, 1973
- Inhibition of Adrenal Corticosteroid Synthesis by Aminoglutethimide: Studies of the Mechanism of Action1Journal of Clinical Endocrinology & Metabolism, 1967
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896